PET/MRI Imaging Comparison for Rectal Cancer Lymph Node Staging
Part of Cancer, Digestive system clinical trials.
This study compares two types of advanced imaging scans (PET/MRI) to see which one better detects cancer spread to lymph nodes in rectal cancer patients planning surgery. The goal is to improve how doctors stage and plan treatment for rectal cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Rectal cancer confirmed by biopsy (tissue sample)
- Tumor location between 5–15 cm from the anus
- Planning to have surgery to remove the cancer
- Good enough health to tolerate imaging (ECOG score 0–2)
- Willing and able to complete two PET/MRI scans
- No prior pelvic radiation or chemotherapy
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether a special scan called PET-MRI can better show how rectal cancer responds to treatment given before surgery. If it works well, it could help doctors plan the right next steps after chemoradiotherapy.
This study is testing a special PET/MRI scan to see if it can better guide treatment for stage 2 or 3 rectal cancer. You may qualify if you have locally advanced rectal cancer and are planning to get chemo and radiation before surgery.
This study looks at how an MRI “score” (mrTRG) matches how well locally advanced rectal cancer shrinks after pre-surgery chemotherapy and radiation. The goal is to use MRI results to better predict treatment response and guide care.
This trial uses a special type of MRI scan (called amide proton transfer-weighted imaging) to look at your rectal cancer before and after chemotherapy and/or radiation. The goal is to see if the scan can predict whether the cancer has completely disappeared by the time of surgery, which could help guide future treatment decisions.
This study uses a special scan called PET/MRI to see how well treatment works for locally advanced rectal cancer before surgery. It may help doctors choose the best treatment plan for you.
This trial looks at two types of scans—18F-FAPI PET/CT and MRI—to see how they compare for people with suspected or diagnosed gastric cancer. The goal is to learn which scan gives better information to help guide care.
Hear when a new Rectal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.